ESC-CHF: guidelines for the aspirational and the practical

被引:19
作者
Brady, AJB [1 ]
Poole-Wilson, PA
机构
[1] Glasgow Royal Infirm, Dept Med Cardiol, Glasgow G4 0SF, Lanark, Scotland
[2] Natl Heart & Lung Inst, London, England
关键词
D O I
10.1136/hrt.2005.083980
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:437 / 440
页数:4
相关论文
共 21 条
  • [11] Fox KM, 2003, LANCET, V362, P782
  • [12] Gerstein HC, 2000, LANCET, V355, P253
  • [13] Rates of hyperkalemia after publication of the randomized aldactone evaluation study
    Juurlink, DN
    Mamdani, MM
    Lee, DS
    Kopp, A
    Austin, PC
    Laupacis, A
    Redelmeier, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (06) : 543 - 551
  • [14] National Institute of Clinical Excellence (NICE), 2003, CHRON HEART FAIL MAN
  • [15] Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
    Pfeffer, MA
    McMurray, JJV
    Velazquez, EJ
    Rouleau, JL
    Kober, L
    Maggioni, AP
    Solomon, SD
    Swedberg, K
    Van de Werf, F
    White, H
    Leimberger, JD
    Henis, M
    Edwards, S
    Zelenkofske, S
    Sellers, MA
    Califf, RM
    Aylward, P
    Armstrong, P
    Barvik, S
    Belenkov, Y
    Dalby, A
    Diaz, R
    Drexler, H
    Ertl, G
    Francis, G
    Hampton, J
    Harsanyi, A
    Kvasnicka, J
    Mareev, V
    Marin-Neto, J
    Murin, J
    Myers, M
    Nordlander, R
    Opolski, G
    Soler-Soler, J
    Spac, J
    Stefenelli, T
    Sugrue, D
    Van Gilst, W
    Varshavsky, S
    Weaver, D
    Zannad, F
    Aguilar, D
    Alvarez, A
    Al-Taweel, M
    Anavekar, N
    Finn, P
    Lopez-Jimenez, F
    Mercier, R
    Lewis, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) : 1893 - 1906
  • [16] Effects of candesartan on mortality and morbidity in patients with chronic heart failure:: the CHARM-Overall programme
    Pfeffer, MA
    Swedberg, K
    Granger, CB
    Held, P
    McMurray, JJV
    Michelson, EL
    Olofsson, B
    Östergren, J
    Yusuf, S
    [J]. LANCET, 2003, 362 (9386) : 759 - 766
  • [17] Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
    Pitt, B
    Remme, W
    Zannad, F
    Neaton, J
    Martinez, F
    Roniker, B
    Bittman, R
    Hurley, S
    Kleiman, J
    Gatlin, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) : 1309 - 1321
  • [18] The effect of spironolactone on morbidity and mortality in patients with severe heart failure
    Pitt, B
    Zannad, F
    Remme, WJ
    Cody, R
    Castaigne, A
    Perez, A
    Palensky, J
    Wittes, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) : 709 - 717
  • [19] Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol, European Trial (COMET): randomised controlled trial
    Poole-Wilson, PA
    Swedberg, K
    Cleland, JGF
    Di Lenarda, A
    Hanrath, P
    Komajda, M
    Lubsen, J
    Lutiger, E
    Metra, M
    Remme, WJ
    Torp-Pedersen, C
    Scherhag, A
    Skene, A
    [J]. LANCET, 2003, 362 (9377) : 7 - 13
  • [20] *SIGN, 1999, DIAGN TREATM HEART F